# RIGEL PHARMACEUTICALS INC (RIGL) — management_change/board [announced]
Source: SEC API (secapi.ai) · situation sit_deea42227e3eb8f2870a · retrieved 2026-08-11T16:01:54.722Z

## Overview
Rigel Pharmaceuticals is a commercial-stage biotechnology company focused on discovering, developing, and providing novel therapies for hematologic disorders and cancer.

Rigel Pharmaceuticals entered into an exclusive, global licensing agreement with Arvinas, Inc. and Pfizer Inc. to develop, manufacture, and commercialize VEPPANU (vepdegestrant), the first and only FDA-approved PROTAC for treating adults with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer. The agreement became effective on June 11, 2026, and Rigel paid an upfront payment of $70.0 million to Arvinas and Pfizer in the second quarter. Rigel immediately initiated launch activities and expects VEPPANU to be commercially available in the United States in mid-August 2026.

## Terms
- Counterparty: Arvinas, Inc. and Pfizer Inc. · Deal value: $70.0M · Consideration: cash

## Key dates
- Announced 2026-08-04

## Timeline
- 2026-08-04 · 8-K (0001034842-26-000053): 8-K - RIGEL PHARMACEUTICALS INC — *Rigel Pharmaceuticals is a commercial-stage biotechnology company focused on discovering, developing, and providing novel therapies for hematologic disorders and cancer.* Rigel Pharmaceuticals entered into an exclusive, global licensing agreement with Arvinas, Inc. and Pfizer Inc. to develop, manufacture, and commercialize VEPPANU (vepdegestrant), the first and only FDA-approved PROTAC for treating adults with ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer. The agreement became effective on June 11, 2026, and Rigel paid an upfront payment of $70.0 million to Arvinas and Pfizer in the second quarter. Rigel immediately initiated launch activities and expects VEPPANU to be commercially available in the United States in mid-August 2026.
  https://www.sec.gov/Archives/edgar/data/1034842/0001034842-26-000053.txt

## Citations
- 0001034842-26-000053 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000103484226000053